TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Oxford BioDynamics ( (GB:OBD) ) has shared an update.
Oxford BioDynamics PLC announced the successful passing of resolutions at its General Meeting, which facilitates the issuance of over 2.3 billion new ordinary shares as part of a significant fundraising effort. This move is expected to enhance the company’s trading position on AIM and increase its total voting rights, impacting stakeholders’ interests and potentially strengthening its market presence.
The most recent analyst rating on (GB:OBD) stock is a Sell with a £0.50 price target. To see the full list of analyst forecasts on Oxford BioDynamics stock, see the GB:OBD Stock Forecast page.
Spark’s Take on GB:OBD Stock
According to Spark, TipRanks’ AI Analyst, GB:OBD is a Underperform.
Oxford BioDynamics’ stock score is primarily impacted by its challenging financial performance, characterized by consistent losses and negative cash flows. Technical analysis indicates bearish momentum, and valuation metrics are unfavorable due to a negative P/E ratio. These factors collectively suggest a high-risk investment with significant financial and operational challenges.
To see Spark’s full report on GB:OBD stock, click here.
More about Oxford BioDynamics
Oxford BioDynamics PLC is a biotechnology company that specializes in developing precision medicine tests using its proprietary EpiSwitch® 3D genomics platform. The company focuses on creating innovative solutions for the healthcare industry, particularly in the field of genomics.
Average Trading Volume: 27,861,480
Technical Sentiment Signal: Strong Sell
Current Market Cap: £5.87M
Learn more about OBD stock on TipRanks’ Stock Analysis page.